Abstract
Purpose and Introduction
A growing number of cancer patients are older adults aged 65 years and older. Patients with cancer are at increased risk for developing osteoporosis, falls, and fractures. We sought to identify the incidence of fractures in older adults who underwent cancer care between January 2013 and December 2015.
Methods
A comprehensive geriatric assessment was performed, and bone densitometry was measured at baseline, with a 2-year follow-up.
Results
In this study, among 304 patients with gastrointestinal, urologic, breast, lung, and gynecologic cancers we evaluated, and who completed the bone density testing (n = 199), 80% had osteoporosis or low bone mass (osteopenia). There was a higher prevalence of osteoporosis in cancer patients (40 vs. 16%, p = 0.05) than in population studies. Vitamin D insufficiency (< 30 ng/ml) was identified in 49% of tested cases (n = 245). Risk factors for low bone mass or osteoporosis were advanced age (p = 0.05), malnutrition (p = 0.04), and frailty (p = 0.01). Over the following 2 years (median follow-up 18 months), there was an incidence of fractures of 110 per 1000 person-years, or 2.8 times higher than reported in individuals without cancer. Risk factors for fractures included advanced age (70–79 vs. 60–69 years, p = 0.05) and frailty (p = 0.03).
Conclusion
Most older cancer patients studied have osteoporosis or low bone mass, resulting in an almost 3-fold increase in fracture risk as compared to epidemiologic studies. Bone health issues are commonly seen in older cancer patients, we recommend universal bone density testing. The initiation of antiresorptive treatment when findings are of osteopenia or osteoporosis will reduce the risk of fractures.
Similar content being viewed by others
References
Lorentzon M, Cummings SR (2015) Osteoporosis: the evolution of a diagnosis. J Intern Med 277(6):650–661
Guise TA (2006) Bone loss and fracture risk associated with cancer therapy. Oncologist 11(10):1121–1131
Chen Z, Maricic M, Aragaki AK et al (2009) Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women’s Health Initiative. Osteoporos Int :J Established Result of Coop Between Eur Found Osteoporos Nat Osteoporos Found USA. 20(4):527–536
Budhia S, Mikyas Y, Tang M, Badamgarav E (2012) Osteoporotic fractures: a systematic review of U.S. healthcare costs and resource utilization. PharmacoEconomics 30(2):147–170
Michael YL, Whitlock EP, Lin JS, Fu R, O'Connor EA, Gold R (2010) Primary care-relevant interventions to prevent falling in older adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 153(12):815–825
Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–M156
Roche JJ, Wenn RT, Sahota O, Moran CG (2005) Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ 331(7529):1374
Gralow JR, Biermann JS, Farooki A et al (2013) NCCN Task Force Report: bone health in cancer care. J Natl Compr Canc Netw 11(Suppl 3):S1–50 quiz S51
Cosman F, de Beur SJ, LeBoff MS et al (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos int :J Established Result Coop Between Eur Found Osteoporos Nat Osteoporos Found USA 25(10):2359–2381
Hillner BE, Ingle JN, Chlebowski RT et al (2003) American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol : Off J Am Soc Clin Oncol 21(21):4042–4057
Hadji P, Aapro MS, Body JJ et al (2017) Management of aromatase inhibitor-associated bone loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. J Bone Oncol 7:1–12
Tremollieres FA, Ceausu I, Depypere H et al (2017) Osteoporosis management in patients with breast cancer: EMAS position statement. Maturitas 95:65–71
Silver DS (2010) Denosumab reduces the incidence of new vertebral fractures in men with prostate cancer. Curr Osteoporos Rep 8(1):1–3
Gnant M, Blaha P, Dubsky P, Exner R, Fitzal F, Sporn E, Panhofer P, Borgo AD, Bigenzahn S, Steger G, Jakesz R (2009). Adjuvant bisphosphonates in endocrine-responsive breast cancer: what is their place in therapy? Ther Adv Med Oncol 1(3):123–136
Gnant M, Pfeiler G, Dubsky PC et al (2015) Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 386(9992):433–443
Aapro M (2006) Improving bone health in patients with early breast cancer by adding bisphosphonates to letrozole: the Z-ZO-E-ZO-FAST program. Breast 15(Suppl 1):S30–S40
Brufsky A (2006) Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update. Semin Oncol 33(2 Suppl 7):S13–S17
Lester JE, Dodwell D, Purohit OP et al (2008) Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer. Clin Cancer Res 14(19):6336–6342
Greenspan SL, Brufsky A, Lembersky BC et al (2008) Risedronate prevents bone loss in breast cancer survivors: a 2-year, randomized, double-blind, placebo-controlled clinical trial. J Clin Oncol : Off J American Soc Clin Oncol 26(16):2644–2652
Bondo L, Eiken P, Abrahamsen B (2013) Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients—a nationwide register-based open cohort study. Osteoporos int :J Established Result Coop Between Eur Found Osteoporos Nat Osteoporos Found USA 24(1):245–252
Cree MW, Juby AG, Carriere KC (2003) Mortality and morbidity associated with osteoporosis drug treatment following hip fracture. Osteoporos int :J Established Result Coop Between Eur Found Osteoporos Nat Osteoporos Found USA 14(9):722–727
Lyles KW, Colon-Emeric CS, Magaziner JS et al (2007) Zoledronic acid in reducing clinical fracture and mortality after hip fracture. N Engl J Med 357:nihpa40967
Kizer JR, Dahlof B, Kjeldsen SE et al (2005) Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study. Hypertension 45(1):46–52
Hartigan I (2007) A comparative review of the Katz ADL and the Barthel Index in assessing the activities of daily living of older people. Int J Older People Nursing 2(3):204–212
Graf C (2008) The Lawton instrumental activities of daily living scale. Am J Nurs 108(4):52–62 quiz 62-53
Walston J, Hadley EC, Ferrucci L et al (2006) Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 54(6):991–1001
Wright NC, Looker AC, Saag KG et al (2014) The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Mineral Res : Off J Am Soc Bone and Mineral Res 29(11):2520–2526
Amin S, Achenbach SJ, Atkinson EJ, Khosla S, Melton LJ 3rd (2014) Trends in fracture incidence: a population-based study over 20 years. J Bone and Mineral Res : Off J Am Soc Bone and Mineral Res 29(3):581–589
Hip fractures are profound threat to quality of life. BMJ 2000;320(7231):C
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70
Cabell L, Pienkowski D, Shapiro R, Janura M (2013) Effect of age and activity level on lower extremity gait dynamics: an introductory study. J Strength Cond Res 27(6):1503–1510
Vernikos J, Schneider VS (2010) Space, gravity and the physiology of aging: parallel or convergent disciplines? Mini-Rev Gerontol 56(2):157–166
Ozcivici E, Luu YK, Adler B et al (2010) Mechanical signals as anabolic agents in bone. Nat Rev Rheumatol 6(1):50–59
Goldring SR (2015) The osteocyte: key player in regulating bone turnover. RMD Open 1(Suppl 1):e000049
Clynes MA, Edwards MH, Buehring B, Dennison EM, Binkley N, Cooper C (2015) Definitions of sarcopenia: associations with previous falls and fracture in a population sample. Calcif Tissue Int 97(5):445–452
Hussain A, Barer D (1995) Fracture risk in Alzheimer’s disease patients. J Am Geriatr Soc 43(4):454
Buchner DM, Larson EB (1987) Falls and fractures in patients with Alzheimer-type dementia. JAMA 257:1492–1495
Guerard EJ, Deal AM, Williams GR, Jolly TA, Nyrop KA, Muss HB (2015) Falls in older adults with cancer: evaluation by oncology providers. J Oncol Pract 11(6):470–4
Schuit SC, van der Klift M, Weel AE et al (2004) Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 34(1):195–202
Siris ES, Chen YT, Abbott TA et al (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164(10):1108–1112
Edwards BJ, Usmani S, Raisch DW et al (2013) Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) project. J Oncol Pract 9(2):101–106
Adler RA, El-Hajj Fuleihan G, Bauer DC et al (2016) Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research. J Bone and Mineral Res : Off J Am Soc Bone and Mineral Res 31(10):1910
Acknowledgements
This study was presented at MASCC/ISOO 2016 Annual Meeting.
Funding
This study was supported by a grant from the University of Texas MD Anderson Cancer Center; the statistical analysis work was supported in part by the Cancer Center Support Grant (NCI Grant P30 CA016672).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The research protocol was approved by the institutional review board.
ᅟ
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Edwards, B.J., Sun, M., Zhang, X. et al. Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experience. Support Care Cancer 26, 1561–1568 (2018). https://doi.org/10.1007/s00520-017-3962-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-017-3962-7